Request Customisation
Speak to Analyst
Get Free Sample Pages
Omega-3 Market
Report Code
FB 2759
Published in
Jul, 2026, By MarketsandMarkets™
Omega-3 Market by Type (DHA, EPA, & ALA), Source (Marine & Plant), Application (Dietary Supplements, Functional Foods & Beverages, Pharmaceuticals, Infant Formulas, and Pet Food & Feed), Form, Manufacturing Technology, and Region - Global Forecast to 2031
USD 8.73 BN
MARKET SIZE, 2031
CAGR 12.3%
(2026-2031)
300
REPORT PAGES
350
MARKET TABLES
OVERVIEW
Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis
The omega-3 market is estimated to be USD 4.88 billion in 2026 and is projected to reach USD 8.73 billion by 2031, at a CAGR of 12.3%. One significant driver is the increasing awareness among consumers of the health benefits associated with omega-3 fatty acids, including their positive effects on heart health, brain function, and joint health. This growing awareness is prompting more individuals to seek out omega-3-rich foods and supplements as part of their daily diet. The rising prevalence of chronic diseases, such as cardiovascular disorders and cognitive decline, is also fueling demand for omega-3 products, which are perceived to have preventive and therapeutic properties.
Market Size and Forecast:
- Market Size Value in 2025: USD 4.36 Billion
- Market Size Value in 2026: USD 4.88 Billion
- Revenue Forecast in 2031: USD 8.73 Billion
- Growth Rate: CAGR of 12.3% from 2026 to 2031
- Data available from 2022 to 2031
- Base year: 2025
- Forecast period: 2026–2031
- North America is estimated to account for the largest market share of 37% in 2026, driven by rising demand for omega-3 products.
- The marine source segment is estimated to dominate with a market share of 93.6% in 2026.
Key Market Trends and Insights
- By Type: DHA, EPA, and ALA remain the key omega-3 fatty acid types, with increasing demand across dietary supplements, functional foods & beverages, pharmaceuticals, infant formula, and pet food & feed applications.
-
Growth Drivers: Rising consumer awareness of the benefits of omega-3 for cardiovascular health, cognitive function, eye health, and overall wellness, coupled with growing demand for preventive healthcare and nutritional supplements, is accelerating market growth.
- Growing Trends: Increasing adoption of plant-based omega-3 sources, advanced manufacturing technologies, fortified functional foods, and high-bioavailability formulations is shaping the future of the omega-3 market.
- Growth Opportunities: Expanding applications in dietary supplements, pharmaceuticals, infant nutrition, functional foods & beverages, and pet nutrition, along with continued innovation in sustainable marine and plant-derived omega-3 ingredients, are creating significant growth opportunities for the omega-3 market.
KEY TAKEAWAYS
-
BY REGIONNorth America is estimated to account for the largest market share of 37% in 2026, driven by rising demand for omega-3 products.
-
BY SOURCEBy source, the marine source segment is estimated to dominate with a market share of 93.6% in 2026.
-
BY APPLICATIONBy application, the infant formula segment is projected to grow at the highest CAGR of 13.6% during the forecast period.
-
BY TYPEBy type, the docosahexaenoic acid (DHA) segment is projected to hold the largest share.
-
COMPETITIVE LANDSCAPE - KEY PLAYERSMajor market players have adopted both organic and inorganic strategies, including partnerships and investments. Companies such as Cargill, Incorporated (US), Kerry Group plc (Ireland), and DSM-Firmenich (Netherlands) have entered into a number of agreements, partnerships, and expansions to cater to the growing demand for omega-3 across innovative applications.
-
COMPETITIVE LANDSCAPECellana Inc. (US), Solutex (Spain), and AlgaeCytes Limited (UK) are emerging as the key startups in this market.
The omega-3 market is experiencing growth driven by multiple factors. One significant driver is the increasing awareness among consumers of the health benefits associated with omega-3 fatty acids, including their positive effects on heart health, brain function, and joint health. This growing awareness is prompting more individuals to seek out omega-3-rich foods and supplements as part of their daily diet. Moreover, the rising prevalence of chronic diseases such as cardiovascular disorders and cognitive decline is fueling demand for omega-3 products, which are perceived to have preventive and therapeutic properties.
TRENDS & DISRUPTIONS IMPACTING CUSTOMERS' CUSTOMERS
The increasing popularity of plant-based diets has led to a growing demand for vegan and vegetarian sources of omega-3, driving innovation in the market with more plant-based omega-3 supplements and fortified foods. Originally sourced from fish oil, krill oil, and other marine oils, the market is now expanding to include algal and plant-based options to meet sustainability and vegetarian demands. The industry has been driven by growing health concerns, improvements in extraction and stabilization technology, and increasing regulatory acceptance for fortified foods. With ongoing innovation in delivery forms and expanded uses, omega-3 ingredients continue to be a central part of the global health and wellness industry, contributing to heart, brain, and eye health and inflammation control.
Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis
MARKET DYNAMICS
Drivers
Impact
Level
Level
-
Growing focus of food processing companies on fortification
-
Emergence of innovative production technologies
RESTRAINTS
Impact
Level
Level
-
Lower fish oil supply due to sustainability issues among fisheries
-
Lack of clarity among consumers about daily recommended intake and health claims
OPPORTUNITIES
Impact
Level
Level
-
Integration of microencapsulation technology
-
Favorable regulatory environment
CHALLENGES
Impact
Level
Level
-
High cost involved in R&D activities
-
Highly unstable fish oil prices
Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis
Driver: Growing focus of food processing companies on fortification
Omega-3 is an important component in functional foods and pharmaceuticals. Traditionally, it was mainly taken as a health supplement. However, as more research has been done and consumers become more aware, marketers have become interested in incorporating omega-3 into different processed foods and beverages, such as dairy products, cereals, and breads. This expansion of omega-3 applications into the food processing industry not only provides consumers with convenient and accessible sources of omega-3 fatty acids but also creates new opportunities for market growth and product innovation within the omega-3 industry.
Restraint: Lack of clarity among consumers about daily recommended intake and health claims
The market for omega-3 in the form of dietary supplements and fortified foods & beverages is facing a significant challenge due to the absence of official recommended doses. Despite extensive scientific research conducted by governments and non-government organizations, there is no clear standard dose of omega-3 for daily intake. This has resulted in confusion among consumers, which can lead to disastrous results. Omega-3 is an important food supplement that can help prevent various health-related issues, such as reducing the risk of heart & metabolic health, brain & mental health, improving brain function, and assisting with other autoimmune diseases. However, non-standard doses result in improper dosage, leading to very few or no health benefits. This situation is particularly concerning in developing countries such as India, China, Brazil, and Argentina, where consumer awareness is low, and there is a lack of adequate primary healthcare infrastructure.
Opportunity: Integration of microencapsulation technology
With a rise in global health consciousness, the demand for fortified beverages, particularly dairy products, has increased significantly. Fortification involves several processes that must maintain the original color, texture, flavor, and nutritional profile of the products. As a result, encapsulation technology is frequently used to offer controlled release of nutrients in fortified food & beverages. Consumers often expect fresh fish oil supplements but are dismayed by the fishy smell caused by oxidation, which raises concerns about product quality and safety. Microencapsulation technology provides a solution by creating stable emulsions of omega-3 oil, thereby enhancing absorption and reducing oxidation risks.
Challenge: High cost involved in R&D activities
The omega-3 market incurs high costs associated with research & development due to various factors. Firstly, exploring alternative sources of omega-3, such as algae or krill, requires significant financial resources for conducting scientific research. Investing in equipment, facilities, and specialized expertise to optimize extraction techniques and maximize yield and purity also involves substantial investment. Moreover, evaluating the efficacy, safety, and health benefits of omega-3 products through clinical trials and studies entails considerable expenses. These trials often involve recruiting participants, conducting tests, collecting data, and analyzing results, all of which incur substantial costs.
OMEGA-3 MARKET: COMMERCIAL USE CASES ACROSS INDUSTRIES
| COMPANY | USE CASE DESCRIPTION | BENEFITS |
|---|---|---|
 |
Aker BioMarine leveraged Vitafoods Europe 2024 as a platform to showcase its dual expertise in marine (krill oil) and plant-based (algae oil) omega-3 solutions. By introducing FloraMarine, an algae-based DHA product, the company demonstrates its ability to meet growing B2B demand for sustainable, plant-based alternatives while maintaining its leadership in marine-derived nutrition. | Aker BioMarine gains stronger market positioning by expanding into the fast-growing plant-based omega-3 space while reinforcing its leadership in sustainable nutrition. The launch at Vitafoods drives brand visibility, customer engagement, and new B2B growth opportunities. |
 |
Epax introduced EPAX Evolve 05, the first commercially available VLC-PUFA (very long chain polyunsaturated fatty acid) concentrate, at Vitafoods Europe 2024. The product, derived from fish oil and enriched to deliver ~10x higher VLC-PUFA content, targets the healthy aging and specialty health markets (vision, bone, muscle, skin, and fertility). | Epax secures a first-mover advantage in the omega-3 market with the world’s first VLC-PUFA concentrate, backed by EU and US regulatory approvals. This launch expands its reach into the healthy aging and specialty health segments while strengthening its reputation as an innovation leader. |
 |
Utilizing its innovative biotechnology platform, in April 2023, MiAlgae successfully launched NaturAlgae, a dry powder with a high concentration of DHA and other oils. This product can be seamlessly integrated into aquafeeds and pet food recipes, providing the well-known health benefits of omega-3. | Following the recent expansion of its commercial production site north of Glasgow, MiAlgae is poised for significant growth in the aquaculture and pet food sectors. |
Logos and trademarks shown above are the property of their respective owners. Their use here is for informational and illustrative purposes only.
MARKET ECOSYSTEM
The market map of the ecosystem is categorized into demand-side and supply-side companies. The omega-3 market is a dynamic and rapidly expanding ecosystem characterized by diverse stakeholders and innovative products. BASF SE (Germany), Cargill, Incorporated (US), DSM-Firmenich (Netherlands), ADM (US), Kerry Group plc (Ireland), Aker BioMarine (Norway), Croda International plc (UK), and Corbion (Netherlands) spearhead product innovation and market penetration, while numerous smaller enterprises enhance the competitive landscape. The ecosystem includes ingredient suppliers, regulatory bodies & associations, small and medium-sized enterprises, and demand-side companies.
Logos and trademarks shown above are the property of their respective owners. Their use here is for informational and illustrative purposes only.
MARKET SEGMENTS
Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis
Omega-3 Market, By Source
The marine segment is poised to dominate the omega-3 market, by source, mainly due to the fact that fish oil and krill oil are naturally high in EPA (eicosapentaenoic acid) and DHA (docosahexaenoic acid), the most bioactive and well-studied forms of omega-3 fatty acids. These two are better absorbed by the human body than plant sources such as ALA (alpha-linolenic acid), and therefore, they are greatly favored for cardiovascular, brain, and eye health.
Omega-3 Market, By Application
Due to their extensively studied health advantages, omega-3 fatty acids are utilized in functional foods and beverages. These indispensable fatty acids, encompassing EPA (eicosapentaenoic acid) and DHA (docosahexaenoic acid), serve vital functions in human health, notably in bolstering cardiovascular health, cognitive function, and mitigating inflammation. Functional foods and beverages offer a convenient avenue for individuals to integrate omega-3 fatty acids into their daily dietary regimen, particularly beneficial for those who may not regularly consume fatty fish, the primary source of omega-3s. Enhanced products like yogurt, milk, juices, bread, and snack bars serve as accessible alternatives for individuals seeking to augment their omega-3 intake without resorting to supplements.
Omega-3 Market, By type
The DHA (docosahexaenoic acid) segment leads the omega-3 market owing to its critical role in brain, eye, and nervous system health, making it essential across all age groups, particularly for infants and aging adults. The primary drivers are increasing consumer knowledge of its role in cognitive development, vision, cardiovascular health, and healthy aging, as well as growing use in infant formulas, functional foods, dietary supplements, and pharmaceuticals.
REGION
Asia Pacific market to grow at significant rate during forecast period
The Asia Pacific omega-3 market is experiencing robust growth as growing spending on health supplement products and increasing knowledge of the health benefits of omega-3s for heart, brain, and joint health fuel demand. In addition to this, the high prevalence of chronic diseases and an aging population in pursuit of preventive healthcare underpin demand. The expanding infant nutrition industry is also a key contributor, as omega-3s play a key role in early brain development. Government health programs and demographic developments are making the market environment conducive to growth. The market will experience the most rapid growth in this region, offering significant growth opportunities for producers. Developing new products is a prime field, such as adding omega-3s to functional foods, drinks, and other ready-to-go formats to attract more consumers. Demand is also increasing for plant- and algae-derived omega-3s due to sustainability and vegan consumerism. Product taste and stability can be improved through technologies such as microencapsulation by manufacturers. Market diversification and expansion can also be achieved through opportunities in animal feed, pharmaceuticals, and clinical nutrition.
OMEGA-3 MARKET: COMPANY EVALUATION MATRIX
In the omega-3 market matrix, DSM-Firmenich (Netherlands) and Cargill, Incorporated (US) are the key star players that lead the market through their high-quality omega-3 ingredients. Life’s DHA from DSM-Firmenich is a plant-based source of docosahexaenoic acid (DHA) omega-3 extracted from algae, delivering crucial advantages for brain and eye health at every life stage. ALGARITHM (Emerging Leader) is gaining traction with its product innovations in the omega-3 market.
Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis
KEY MARKET PLAYERS
- Cargill, Incorporated (US)
- ADM (US)
- Kerry Group plc (Ireland)
- dsm-firmenich (Netherlands)
- BASF (Germany)
- Aker BioMarine (Norway)
- Croda International plc (UK)
- Corbion (Netherlands)
- Pelagia AS (Norway)
- GC Rieber (Norway)
- Cooke Aquaculture Inc. (Canada)
- Golden Omega (Chile)
- Polaris (France)
- Btsa (Spain)
- KinOmega Biopharm Inc. (China)
MARKET SCOPE
| REPORT METRIC | DETAILS |
|---|---|
| Market Size in 2026 (Value) | USD 4.88 Billion |
| Market Forecast in 2031 (value) | USD 8.73 Billion |
| Growth Rate | 12.30% |
| Years Considered | 2022–2031 |
| Base Year | 2025 |
| Forecast Period | 2026–2031 |
| Units Considered | Value (USD Million/Billion), Volume (Kiloton) |
| Report Coverage | Revenue forecast, market share, competitive landscape, growth factors, and trends |
| Segments Covered | Type, source, application, form, manufacturing technology (qualitative), and region |
| Regions Covered | North America, Europe, Asia Pacific, South America, and Rest of the World (RoW) |
WHAT IS IN IT FOR YOU: OMEGA-3 MARKET REPORT CONTENT GUIDE
DELIVERED CUSTOMIZATIONS
We have successfully delivered the following deep-dive customizations:
| CLIENT REQUEST | CUSTOMIZATION DELIVERED | VALUE ADDS |
|---|---|---|
| APAC-based Omega-3 Manufacturers |
|
|
| Functional Food Segment Assessment |
|
|
RECENT DEVELOPMENTS
- April 2026 : DSM-Firmenich launched Veramaris O3 Max Pure at Petfood Forum 2026, introducing the world's first microalgal omega-3 oil with the same natural 3:2 EPA:DHA ratio as high-quality fish oil. The product was designed as a non-GMO, vegan, and sustainable fish oil replacement for pet food formulations.
- April 2026 : Fermentalg launched OMEGA ΩRIGINS EPA/DHA, a next-generation microalgae-derived omega-3 oil featuring the industry's first naturally achieved 40% EPA and 20% DHA (400/200) ratio without any concentration process. Produced using a patented fermentation technology and proprietary Schizochytrium strain, the product would deliver up to 60% total omega-3 content and is targeted at dietary supplements, functional foods & beverages, and pet nutrition.
- July 2025 : Corbion received regulatory approval in China for its algae-based omega-3 solutions, marking a significant milestone in its global expansion strategy. These omega-3 ingredients, derived from microalgae, were designed for use in nutritional supplements, functional foods, and beverages, offering a sustainable and plant-based alternative to traditional fish oil. The approval enabled Corbion to enter one of the world’s largest and fastest-growing markets for health and wellness products, reinforcing its commitment to innovation and environmental responsibility in the nutraceutical sector.
- April 2025 : Epax, a subsidiary of Pelagia AS, launched EPAX Evolve 05, the world’s first commercially available VLC-PUFA (Very Long Chain Polyunsaturated Fatty Acid) product. VLC-PUFAs are a unique class of omega-3 fatty acids with promising benefits for vision, skin health, male fertility, bone density, and muscle strength, especially in the context of healthy aging.
- March 2025 : Nordmann (Germany) partnered with Aker BioMarine to distribute its marine-based health products, Superba krill oil, Revervia algae oil, and pl+, across Germany, Austria, and Switzerland. These products are rich in essential omega-3 fatty acids, particularly EPA and DHA, which support heart and liver health. Superba krill oil delivers omega-3s in phospholipid form for better absorption, while Revervia offers the highest natural concentration of DHA omega-3 from algae. This strategic collaboration aimed to expand access to sustainable, high-quality omega-3 supplements in Central Europe.
Table of Contents
Exclusive indicates content/data unique to MarketsandMarkets and not available with any competitors.
TITLE
PAGE NO
1
INTRODUCTION
29
2
EXECUTIVE SUMMARY
35
3
PREMIUM INSIGHTS
41
4
MARKET OVERVIEW
Explore booming omega-3 market driven by health trends, innovation, and sustainability challenges.
45
4.1
INTRODUCTION
4.2
MARKET DYNAMICS
4.2.1
DRIVERS
4.2.1.1
GROWING CONSUMER AWARENESS REGARDING HEALTH BENEFITS
4.2.1.2
INCREASING USE IN FOOD AND FEED PRODUCTS
4.2.1.2.1
RISING DEMAND FOR MOTHER AND INFANT NUTRITION PRODUCTS
4.2.1.2.2
MANDATORY INCLUSION OF ALGAL DHA IN INFANT FORMULA
4.2.1.2.3
GROWTH FOCUS OF FOOD PROCESSING COMPANIES ON FORTIFICATION
4.2.1.2.4
INCREASING APPLICATIONS IN PET FOOD AND FEED
4.2.1.3
SHIFT TOWARD PHARMACEUTICAL-GRADE HIGH-CONCENTRATE OMEGA-3 OILS IN DEVELOPED MARKETS
4.2.1.4
EMERGENCE OF INNOVATIVE PRODUCTION TECHNOLOGIES
4.2.2
RESTRAINTS
4.2.2.1
DECLINING FISH OIL SUPPLY DUE TO SUSTAINABILITY ISSUES IN FISHERIES
4.2.2.2
LACK OF CLARITY ON DAILY INTAKE RECOMMENDATIONS AND HEALTH CLAIMS
4.2.3
OPPORTUNITIES
4.2.3.1
INCREASING RESEARCH ON ALTERNATIVE SOURCES
4.2.3.1.1
RISING CONSUMER DEMAND FOR PLANT-BASED PRODUCTS
4.2.3.1.2
GROWING FOCUS ON MICROALGAE-BASED OMEGA-3 PRODUCTION
4.2.3.1.3
SIDE EFFECTS AND ALLERGIES RELATED TO FISH-BASED PRODUCTS
4.2.3.2
FAVORABLE REGULATORY ENVIRONMENT
4.2.3.3
INTEGRATION OF MICROENCAPSULATION TECHNOLOGY
4.2.4
CHALLENGES
4.2.4.1
HIGH COSTS INVOLVED IN R&D ACTIVITIES
4.2.4.2
VOLATILITY IN FISH OIL PRICES
4.2.4.3
INSTABILITY OF OMEGA-3 OILS
4.3
UNMET NEEDS AND WHITE SPACES
4.3.1
UNMET NEEDS IN THE OMEGA 3 MARKET
4.3.2
WHITE SPACE OPPORTUNITIES
4.4
INTERCONNECTED MARKETS AND CROSS-SECTOR OPPORTUNITIES
4.4.1
INTERCONNECTED MARKETS
4.4.2
CROSS SECTOR OPPORTUNITIES
4.5
STRATEGIC MOVES BY TIER-1/2/3 PLAYERS
5
INDUSTRY TRENDS
Navigate competitive dynamics and capitalize on emerging opportunities within the omega-3 industry landscape.
63
5.1
PORTER’S FIVE FORCES ANALYSIS
5.1.1
INTENSITY OF COMPETITIVE RIVALRY
5.1.2
BARGAINING POWER OF SUPPLIERS
5.1.3
BARGAINING POWER OF BUYERS
5.1.4
THREAT OF SUBSTITUTES
5.1.5
THREAT OF NEW ENTRANTS
5.2
MACROECONOMIC OUTLOOK
5.2.1
INTRODUCTION
5.3
MACROECONOMIC INDICATORS
5.3.1
SUSTAINABILITY AND CIRCULAR ECONOMY INITIATIVES
5.3.2
PREVENTIVE HEALTHCARE EXPENDITURE
5.3.3
GROWING GERIATRIC POPULATION
5.4
VALUE CHAIN ANALYSIS
5.4.1
RESEARCH AND PRODUCT DEVELOPMENT
5.4.2
SOURCING
5.4.3
PRODUCTION AND PROCESSING
5.4.4
DISTRIBUTION
5.4.5
MARKETING AND SALES
5.4.6
END USERS
5.5
ECOSYSTEM ANALYSIS
5.5.1
DEMAND SIDE
5.5.2
SUPPLY SIDE
5.6
PRICING ANALYSIS
5.6.1
INTRODUCTION
5.6.2
AVERAGE SELLING PRICE OF OMEGA-3 FINISHED PRODUCTS, BY PRODUCT TYPE
5.6.3
AVERAGE SELLING PRICE (ASP) TREND, BY REGION
5.6.4
AVERAGE SELLING PRICE (ASP) TREND, BY SOURCE
5.7
TRADE ANALYSIS
5.7.1
IMPORT ANALYSIS: OMEGA-3
5.7.2
EXPORT ANALYSIS: OMEGA-3
5.8
KEY CONFERENCES AND EVENTS, 2026–2027
5.9
TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES
5.10
INVESTMENT AND FUNDING SCENARIO
5.11
CASE STUDY ANALYSIS
5.11.1
MIALGAE INTRODUCED SUSTAINABLE OMEGA-3 PRODUCTION WITH INNOVATIVE BIOTECHNOLOGY
5.11.2
KD PHARMA GROUP: ADVANCING PHARMACEUTICAL-GRADE OMEGA-3 PURIFICATION TECHNOLOGIES
5.11.3
VERAMARIS: PIONEERING SUSTAINABLE OMEGA-3 SOLUTIONS IN AQUACULTURE
5.11.4
DSM-FIRMENICH: EXPANDING ALGAE-DERIVED DHA ACROSS LIFE-STAGE NUTRITION
5.11.5
AKER BIOMARINE EXPANDED EUROPEAN MARKET ACCESS THROUGH STRATEGIC DISTRIBUTION PARTNERSHIPS
5.12
IMPACT OF 2025 US TARIFFS - OMEGA-3 MARKET
5.12.1
INTRODUCTION
5.12.2
PRICE IMPACT ANALYSIS
5.12.3
IMPACT ON COUNTRIES/REGIONS
5.12.3.1
US
5.12.3.2
EUROPE
5.12.3.3
ASIA PACIFIC
5.12.4
IMPACT ON END-USE INDUSTRIES
6
TECHNOLOGY ADVANCEMENTS, AI-DRIVEN IMPACT, PATENTS, INNOVATIONS, AND FUTURE APPLICATIONS
AI-driven technologies revolutionize sustainable omega-3 production, enhancing precision nutrition and market innovation.
84
6.1
TECHNOLOGY ANALYSIS
6.1.1
KEY TECHNOLOGIES
6.1.1.1
MOLECULAR DISTILLATION
6.1.1.2
SUPERCRITICAL CO2 EXTRACTION
6.1.1.3
ALGAE FERMENTATION
6.1.2
COMPLEMENTARY TECHNOLOGIES
6.1.2.1
STABILIZATION & ANTIOXIDANT TECHNOLOGIES
6.1.2.2
MICROENCAPSULATION
6.1.3
ADJACENT TECHNOLOGIES
6.1.3.1
PRECISION FERMENTATION
6.1.3.2
SYNTHETIC BIOLOGY & BIOPROCESS ENGINEERING
6.1.4
TECHNOLOGY/PRODUCT ROADMAP
6.1.4.1
SHORT-TERM | HIGH-PURITY OMEGA-3 PRODUCTION & STABILITY ENHANCEMENT
6.1.4.2
MID-TERM | SUSTAINABLE EPA & DHA MANUFACTURING
6.1.4.3
LONG-TERM | PRECISION NUTRITION & NEXT-GENERATION OMEGA-3 INNOVATION
6.2
PATENT ANALYSIS
6.3
FUTURE APPLICATIONS
6.3.1
CLINICAL NUTRITION & HEALTHY AGING: EXPANDING THE FUTURE OF OMEGA-3 APPLICATIONS
6.3.2
STABLE DHA-ENRICHED FUNCTIONAL FOODS: ADVANCING THE NEXT GENERATION OF OMEGA-3 NUTRITION
6.3.3
PLANT-BASED OMEGA-3 SUPPLEMENTATION: ENABLING THE FUTURE OF PERSONALIZED VEGAN NUTRITION
6.3.4
OMEGA-3 BIOMARKER-BASED PRENATAL NUTRITION: ENABLING PRECISION MATERNAL HEALTHCARE
6.4
IMPACT OF GENERATIVE AI ON OMEGA 3 MARKET
6.4.1
INTRODUCTION
6.4.2
TOP USE CASES AND MARKET POTENTIAL
6.4.3
BEST PRACTICES IN OMEGA 3 INDUSTRY
6.4.4
CASE STUDIES OF AI IMPLEMENTATION IN OMEGA 3 MARKET
6.4.5
INTERCONNECTED ADJACENT ECOSYSTEM AND IMPACT ON MARKET PLAYERS
6.4.6
CLIENTS’ READINESS TO ADOPT GENERATIVE AI FOR OMEGA 3 PRODUCTION
6.5
SUCCESS STORIES AND REAL-WORLD APPLICATIONS
7
SUSTAINABILITY AND REGULATORY LANDSCAPE
Prepare for evolving global regulations and advanced tech in omega-3 sustainability and compliance.
96
7.1
REGIONAL REGULATIONS AND COMPLIANCE
7.1.1
INDUSTRY STANDARDS
7.1.2
LABELING REQUIREMENTS AND CLAIMS
7.1.3
ANTICIPATED REGULATORY CHANGES IN NEXT 5-10 YEARS
7.1.3.1
ENHANCED TRACEABILITY AND SUSTAINABILITY REQUIREMENTS
7.1.3.2
GLOBAL HARMONIZATION OF OMEGA-3 LABELING AND HEALTH CLAIMS
7.1.3.3
STRICTER QUALITY, PURITY, AND CONTAMINANT STANDARDS
7.1.3.4
DIGITAL TRACEABILITY, AI-ENABLED QUALITY MONITORING, AND COMPLIANCE AUTOMATION
7.1.3.5
STRONGER SUSTAINABILITY AND ESG COMPLIANCE REQUIREMENTS
7.2
SUSTAINABILITY INITIATIVES
7.2.1
SUSTAINABLE SOURCING
7.2.2
CARBON FOOTPRINT REDUCTION INITIATIVES
7.2.3
CIRCULAR ECONOMY APPROACHES
7.3
SUSTAINABILITY IMPACT AND REGULATORY POLICY INITIATIVES
7.4
CERTIFICATIONS, LABELING, ECO-STANDARDS
8
CUSTOMER LANDSCAPE AND BUYER BEHAVIOR
Unlock revenue growth by understanding stakeholder influence and unmet needs in the buying process.
105
8.1
DECISION-MAKING PROCESS
8.2
KEY STAKEHOLDERS AND BUYING CRITERIA
8.2.1
KEY STAKEHOLDERS IN BUYING PROCESS
8.2.2
BUYING CRITERIA
8.3
ADOPTION BARRIERS AND INTERNAL CHALLENGES
8.4
UNMET NEEDS OF VARIOUS APPLICATION INDUSTRIES ACROSS SUPPLY CHAIN
8.5
MARKET PROFITABILITY
8.6
REVENUE POTENTIAL
8.6.1
COST DYNAMICS
9
OMEGA-3 MARKET, BY TYPE
Market Size & Growth Rate Forecast Analysis to 2031 in USD Million | 11 Data Tables
114
9.1
INTRODUCTION
9.2
DOCOSAHEXAENOIC ACID
9.2.1
NEED FOR PROTECTION AGAINST ALZHEIMER'S DISEASE TO DRIVE DEMAND
9.3
EICOSAPENTAENOIC ACID
9.3.1
ABILITY TO REDUCE SUSCEPTIBILITY TO CARDIOVASCULAR DISEASES TO BOOST DEMAND
9.4
ALPHA-LINOLENIC ACID
9.4.1
GROWING POPULARITY AMONG VEGETARIANS AND VEGANS TO BOOST DEMAND
10
OMEGA-3 MARKET, BY SOURCE
Market Size & Growth Rate Forecast Analysis to 2031 in USD Million | 29 Data Tables
121
10.1
INTRODUCTION
10.2
MARINE
10.2.1
NEED FOR HEALTHY FETAL DEVELOPMENT IN PREGNANT WOMEN TO DRIVE MARKET
10.2.2
FISH
10.2.2.1
ANCHOVY
10.2.2.2
SARDINE
10.2.2.3
MACKEREL
10.2.2.4
OTHER FISH TYPES
10.2.3
ALGAE
10.2.3.1
SCHIZOCHYTRIUM SP.
10.2.3.2
CRYPTHECODINIUM COHNII
10.2.3.3
NANNOCHLOROPSIS SP.
10.2.3.4
OTHER ALGAE TYPES
10.2.4
KRILL
10.2.5
OTHER MARINE SOURCES
10.3
PLANT
10.3.1
GROWING USE OF FLAX SEEDS FOR CANCER PREVENTION TO BOOST DEMAND
10.3.2
NUTS & SEEDS
10.3.3
VEGETABLE OILS
11
OMEGA-3 MARKET, BY APPLICATION
Market Size & Growth Rate Forecast Analysis to 2031 in USD Million | 12 Data Tables
136
11.1
INTRODUCTION
11.2
DIETARY SUPPLEMENTS
11.2.1
GROWING IMPORTANCE OF BALANCED AND NUTRITIOUS DIETS TO DRIVE DEMAND
11.3
FUNCTIONAL FOODS & BEVERAGES
11.3.1
ABILITY TO BOOST CARDIOVASCULAR HEALTH TO DRIVE DEMAND
11.3.2
DAIRY & DAIRY ALTERNATIVES
11.3.3
BAKERY & CEREAL PRODUCTS
11.3.4
CONFECTIONERY PRODUCTS
11.3.5
MEAT & MEAT PRODUCTS
11.3.6
BEVERAGES
11.3.7
OTHER FUNCTIONAL FOOD PRODUCTS
11.4
PHARMACEUTICALS
11.4.1
GROWING NEED TO LOWER ELEVATED TRIGLYCERIDE LEVELS TO DRIVE MARKET
11.5
INFANT FORMULAS
11.5.1
RISING CONSUMPTION OF OMEGA-3 DHA DURING PREGNANCY TO BOOST DEMAND
11.6
PET FOOD & FEED
11.6.1
GREATER EMPHASIS ON ENHANCING IMMUNITY IN PETS TO DRIVE MARKET
11.6.2
PET FOOD
11.6.3
ANIMAL FEED
12
OMEGA-3 MARKET, BY FORM
Market Size & Growth Rate Forecast Analysis to 2031 in USD Million | 6 Data Tables
146
12.1
INTRODUCTION
12.2
DRY
12.2.1
ENCAPSULATED STABILITY MEETS VERSATILE APPLICATIONS
12.3
LIQUID
12.3.1
HIGH BIOAVAILABILITY AND EFFICACY TO FUEL DEMAND
13
OMEGA 3 MARKET, BY MANUFACTURING TECHNOLOGY
Market Size & Growth Rate Forecast Analysis
151
13.1
INTRODUCTION
13.2
EXTRACTION
13.3
REFINING & PURIFICATION
13.4
CONCENTRATION & CONVERSION
13.5
ENCAPSULATION & STABILIZATION
13.6
FERMENTATION & BIOTECHNOLOGY
14
OMEGA-3 MARKET, BY REGION
Comprehensive coverage of 9 Regions with country-level deep-dive of 16 Countries | 158 Data Tables.
154
14.1
INTRODUCTION
14.2
NORTH AMERICA
14.2.1
US
14.2.1.1
GROWING INCORPORATION OF OMEGA-3 IN DIETARY SUPPLEMENTS TO DRIVE MARKET
14.2.2
CANADA
14.2.2.1
INCREASING APPLICATION IN FUNCTIONAL FOODS & BEVERAGES TO BOOST MARKET
14.2.3
MEXICO
14.2.3.1
GROWING FOCUS ON HEART DISEASE PREVENTION TO DRIVE MARKET
14.3
EUROPE
14.3.1
GERMANY
14.3.1.1
LOW FISH CONSUMPTION TO BOOST DEMAND FOR OMEGA-3-BASED SUPPLEMENTS
14.3.2
UK
14.3.2.1
RISING GASTROINTESTINAL HEALTH AWARENESS SUPPORTING OMEGA-3 DEMAND
14.3.3
FRANCE
14.3.3.1
RISING CARDIOVASCULAR DISEASE BURDEN DRIVING OMEGA-3 CONSUMPTION
14.3.4
NORWAY
14.3.4.1
PRODUCTION OF GENETICALLY MODIFIED CANOLA TO OFFER LUCRATIVE GROWTH OPPORTUNITIES TO MARKET PLAYERS
14.3.5
ITALY
14.3.5.1
HIGH PRODUCTION OF DIETARY SUPPLEMENTS, FUNCTIONAL FOOD PRODUCTS, AND BEVERAGES TO BOOST MARKET
14.3.6
SPAIN
14.3.6.1
RISING CONSUMER AWARENESS AND DIETARY GAPS TO DRIVE MARKET
14.3.7
NETHERLANDS
14.3.7.1
GROWING INCIDENCES OF DEPRESSION, AUTISM, AND ADHD TO DRIVE MARKET
14.3.8
REST OF EUROPE
14.4
ASIA PACIFIC
14.4.1
CHINA
14.4.1.1
INCREASING FOCUS ON PRODUCT INNOVATIONS AND DIVERSIFICATION TO DRIVE MARKET
14.4.2
INDIA
14.4.2.1
GROWING INCIDENCES OF HEART FAILURE TO DRIVE MARKET
14.4.3
JAPAN
14.4.3.1
RAPIDLY AGING POPULATION DRIVING DEMAND FOR OMEGA-3 SUPPLEMENTS
14.4.4
AUSTRALIA & NEW ZEALAND
14.4.4.1
GOVERNMENT-LED INITIATIVES TO INCREASE AWARENESS REGARDING OMEGA-3 TO DRIVE MARKET
14.4.5
REST OF ASIA PACIFIC
14.5
SOUTH AMERICA
14.5.1
BRAZIL
14.5.1.1
RISING DEMAND FOR ALGAL OILS TO DRIVE MARKET
14.5.2
ARGENTINA
14.5.2.1
COMMERCIALIZATION OF OMEGA-3 PRODUCTS TO FUEL MARKET
14.5.3
REST OF SOUTH AMERICA
14.6
REST OF THE WORLD (ROW)
14.6.1
AFRICA
14.6.1.1
PREVALENCE OF UNDERNUTRITION AMONG PREGNANT WOMEN AND CHILDREN TO DRIVE MARKET
14.6.2
MIDDLE EAST
14.6.2.1
ONGOING INNOVATIONS IN OMEGA-3 PRODUCTS TO DRIVE MARKET
15
COMPETITIVE LANDSCAPE
Discover Omega-3 market leaders' strategies and market share dominance through 2025.
212
15.1
OVERVIEW
15.2
KEY PLAYER STRATEGIES/RIGHT TO WIN
15.3
REVENUE ANALYSIS
15.4
MARKET SHARE ANALYSIS
15.5
COMPANY VALUATION AND FINANCIAL METRICS
15.6
OMEGA-3 MARKET: BRAND/PRODUCT COMPARISON
15.7
COMPANY EVALUATION MATRIX: KEY PLAYERS, 2025
15.7.1
STARS
15.7.2
EMERGING LEADERS
15.7.3
PERVASIVE PLAYERS
15.7.4
PARTICIPANTS
15.7.5
COMPANY FOOTPRINT: KEY PLAYERS
15.7.5.1
COMPANY FOOTPRINT
15.7.5.2
REGIONAL FOOTPRINT
15.7.5.3
SOURCE FOOTPRINT
15.7.5.4
TYPE FOOTPRINT
15.7.5.5
APPLICATION FOOTPRINT
15.8
COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2024
15.8.1
PROGRESSIVE COMPANIES
15.8.2
RESPONSIVE COMPANIES
15.8.3
DYNAMIC COMPANIES
15.8.4
STARTING BLOCKS
15.8.5
COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2024
15.9
COMPETITIVE SCENARIO AND TRENDS
15.9.1
OMEGA-3 MARKET: PRODUCT LAUNCHES
15.9.2
DEALS
15.9.3
EXPANSIONS
16
COMPANY PROFILES
In-depth Company Profiles of Leading Market Players with detailed Business Overview, Product and Service Portfolio, Recent Developments, and Unique Analyst Perspective (MnM View)
234
16.1
KEY PLAYERS
16.1.1
DSM-FIRMENICH
16.1.1.1
BUSINESS OVERVIEW
16.1.1.2
PRODUCTS/SOLUTIONS/SERVICES OFFERED
16.1.1.3
RECENT DEVELOPMENTS
16.1.1.3.1
PRODUCT LAUNCHES AND ENHANCEMENTS
16.1.1.4
MNM VIEW
16.1.1.4.1
KEY STRENGTHS
16.1.1.4.2
STRATEGIC CHOICES
16.1.1.4.3
WEAKNESSES AND COMPETITIVE THREATS
16.1.2
CARGILL, INCORPORATED
16.1.3
BASF SE
16.1.4
ADM
16.1.5
KERRY GROUP PLC
16.1.6
CORBION
16.1.7
KD PHARMA GROUP SA
16.1.8
AKER BIOMARINE
16.1.9
CRODA INTERNATIONAL PLC
16.1.10
EVONIK INDUSTRIES AG
16.1.11
PELAGIA
16.1.12
GC RIEBER
16.1.13
COOKE AQUACULTURE INC.
16.1.14
ALGISYS BIOSCIENCES, INC.
16.1.15
POLARIS
16.2
OTHER PLAYERS
16.2.1
BTSA
16.2.2
NOVOSANA EUROPE B.V.
16.2.3
GOLDEN OMEGA
16.2.4
KINOMEGA BIOPHARM INC.
16.2.5
RIMFROST AS
16.2.6
ALGARITHM
16.2.7
SOLUTEX
16.2.8
CELLANA INC.
16.2.9
SINOMEGA BIOTECH ENGINEERING CO., LTD.
16.2.10
ALGAECYTES LIMITED
17
RESEARCH METHODOLOGY
301
17.1
RESEARCH DATA
17.1.1
SECONDARY DATA
17.1.1.1
KEY DATA FROM SECONDARY SOURCES
17.1.2
PRIMARY DATA
17.1.2.1
KEY DATA FROM PRIMARY SOURCES
17.1.2.2
BREAKDOWN OF PRIMARY PROFILES
17.1.2.3
KEY INSIGHTS FROM INDUSTRY EXPERTS
17.2
MARKET SIZE ESTIMATION
17.2.1
TOP-DOWN APPROACH
17.2.2
SUPPLY-SIDE ANALYSIS
17.2.3
BOTTOM-UP APPROACH (DEMAND SIDE)
17.3
DATA TRIANGULATION AND MARKET BREAKUP
17.4
RESEARCH ASSUMPTIONS
17.5
RESEARCH LIMITATIONS AND RISK ASSESSMENT
18
ADJACENT & RELATED MARKETS
311
18.1
INTRODUCTION
18.2
STUDY LIMITATIONS
18.3
FUNCTIONAL FOOD INGREDIENTS MARKET
18.3.1
MARKET DEFINITION
18.3.2
MARKET OVERVIEW
18.4
MARINE COLLAGEN MARKET
18.4.1
MARKET DEFINITION
18.4.2
MARKET OVERVIEW
19
APPENDIX
315
19.1
DISCUSSION GUIDE
19.2
KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
19.3
CUSTOMIZATION OPTIONS
19.4
RELATED REPORTS
19.5
AUTHOR DETAILS
LIST OF TABLES
TABLE 1
INCLUSIONS AND EXCLUSIONS
TABLE 2
USD EXCHANGE RATES, 2021–2025
TABLE 3
HEALTH BENEFITS ASSOCIATED WITH OMEGA-3 CONSUMPTION
TABLE 4
UPCOMING ALTERNATIVE SOURCES FOR OMEGA-3 FATTY ACIDS
TABLE 5
KEY MOVES AND STRATEGIC FOCUS
TABLE 6
OMEGA-3 MARKET: PORTER’S FIVE FORCES ANALYSIS
TABLE 7
OMEGA-3 MARKET: SUPPLY CHAIN (ECOSYSTEM)
TABLE 8
AVERAGE SELLING PRICE (ASP) TREND, BY REGION, 2022–2025 (USD/TON)
TABLE 9
AVERAGE SELLING PRICE (ASP) TREND, BY SOURCE, 2022–2025 (USD/TON)
TABLE 10
TOP IMPORTERS OF OMEGA-3, 2022–2025 (USD)
TABLE 11
TOP EXPORTERS OF OMEGA-3, 2022–2025 (USD)
TABLE 12
OMEGA-3 MARKET: LIST OF KEY CONFERENCES AND EVENTS, 2026–2027
TABLE 13
PATENTS PERTAINING TO OMEGA 3 MARKET, 2021–2026
TABLE 14
TOP USE CASES AND MARKET POTENTIAL
TABLE 15
BEST PRACTICES: COMPANIES IMPLEMENTING USE CASES
TABLE 16
OMEGA 3 MARKET: CASE STUDIES RELATED TO GEN AI IMPLEMENTATION
TABLE 17
INTERCONNECTED ADJACENT ECOSYSTEM AND IMPACT ON MARKET PLAYERS
TABLE 18
NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 19
EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 20
ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 21
SOUTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 22
REST OF THE WORLD: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 23
INTERNATIONAL: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 24
INDUSTRY STANDARDS IN OMEGA-3 MARKET
TABLE 25
LABELING REQUIREMENTS AND CLAIMS IN OMEGA-3 MARKET
TABLE 26
CERTIFICATIONS, LABELING, AND ECO-STANDARDS IN OMEGA-3 MARKET
TABLE 27
INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR KEY PRODUCT TYPES
TABLE 28
KEY BUYING CRITERIA FOR TOP PRODUCT TYPES
TABLE 29
UNMET NEEDS IN OMEGA MARKET, BY APPLICATION INDUSTRIES ACROSS THE SUPPLY CHAIN
TABLE 30
COST DYNAMICS IN OMEGA 3 MARKET
TABLE 31
OMEGA-3 MARKET, BY TYPE, 2022–2025 (USD MILLION)
TABLE 32
OMEGA-3 MARKET, BY TYPE, 2026–2031 (USD MILLION)
TABLE 33
FOOD SOURCES FOR DHA (GRAMS PER SERVING)
TABLE 34
DOCOSAHEXAENOIC ACID MARKET, BY REGION, 2022–2025 (USD MILLION)
TABLE 35
DOCOSAHEXAENOIC ACID MARKET, BY REGION, 2026–2031 (USD MILLION)
TABLE 36
FOOD SOURCES FOR EPA (GRAMS PER SERVING)
TABLE 37
EICOSAPENTAENOIC ACID MARKET, BY REGION, 2022–2025 (USD MILLION)
TABLE 38
EICOSAPENTAENOIC ACID MARKET, BY REGION, 2026–2031 (USD MILLION)
TABLE 39
FOOD SOURCES FOR ALA (GRAMS PER SERVING)
TABLE 40
ALPHA-LINOLENIC ACID MARKET, BY REGION, 2022–2025 (USD MILLION)
TABLE 41
ALPHA-LINOLENIC ACID MARKET, BY REGION, 2026–2031 (USD MILLION)
TABLE 42
OMEGA-3 MARKET, BY SOURCE, 2022–2025 (USD MILLION)
TABLE 43
OMEGA-3 MARKET, BY SOURCE, 2026–2031 (USD MILLION)
TABLE 44
OMEGA-3 MARKET, BY SOURCE, 2022–2025 (KILOTONS)
TABLE 45
OMEGA-3 MARKET, BY SOURCE, 2026–2031 (KILOTONS)
TABLE 46
MARINE-BASED FOOD SOURCES CONTAINING OMEGA-3 ACIDS
TABLE 47
OMEGA-3 MARKET FROM MARINE SOURCES, BY REGION, 2022–2025 (USD MILLION)
TABLE 48
OMEGA-3 MARKET FROM MARINE SOURCES, BY REGION, 2026–2031 (USD MILLION)
TABLE 49
OMEGA-3 MARKET FROM MARINE SOURCE, BY REGION, 2022–2025 (KILOTONS)
TABLE 50
OMEGA-3 MARKET FROM MARINE SOURCES, BY REGION, 2026–2031 (KILOTONS)
TABLE 51
OMEGA-3 MARKET FROM MARINE SOURCES, BY SOURCE TYPE, 2022–2025 (USD MILLION)
TABLE 52
OMEGA-3 MARKET FROM MARINE SOURCES, BY SOURCE TYPE, 2026–2031 (USD MILLION)
TABLE 53
OMEGA-3 MARKET FROM FISH, BY REGION, 2022–2025 (USD MILLION)
TABLE 54
OMEGA-3 MARKET FROM FISH, BY REGION, 2026–2031 (USD MILLION)
TABLE 55
OMEGA-3 MARKET FROM ALGAE, BY REGION, 2022–2025 (USD MILLION)
TABLE 56
OMEGA-3 MARKET FROM ALGAE, BY REGION, 2026–2031 (USD MILLION)
TABLE 57
OMEGA-3 MARKET FROM KRILL, BY REGION, 2022–2025 (USD MILLION)
TABLE 58
OMEGA-3 MARKET FROM KRILL, BY REGION, 2026–2031 (USD MILLION)
TABLE 59
OMEGA-3 MARKET FROM OTHER MARINE SOURCES, BY REGION, 2022–2025 (USD MILLION)
TABLE 60
OMEGA-3 MARKET FROM OTHER MARINE SOURCES, BY REGION, 2026–2031 (USD MILLION)
TABLE 61
OMEGA-3 MARKET FROM PLANT SOURCES, BY REGION, 2022–2025 (USD MILLION)
TABLE 62
OMEGA-3 MARKET FROM PLANT SOURCES, BY REGION, 2026–2031 (USD MILLION)
TABLE 63
OMEGA-3 MARKET FROM PLANT SOURCES, BY REGION, 2022–2025 (KILOTONS)
TABLE 64
OMEGA-3 MARKET FROM PLANT SOURCES, BY REGION, 2026–2031 (KILOTONS)
TABLE 65
OMEGA-3 MARKET FROM PLANT SOURCES, BY SOURCE TYPE, 2022–2025 (USD MILLION)
TABLE 66
OMEGA-3 MARKET FROM PLANT SOURCES, BY SOURCE TYPE, 2026–2031 (USD MILLION)
TABLE 67
OMEGA-3 MARKET FROM NUTS & SEEDS, BY REGION, 2022–2025 (USD MILLION)
TABLE 68
OMEGA-3 MARKET FROM NUTS & SEEDS, BY REGION, 2026–2031 (USD MILLION)
TABLE 69
OMEGA-3 MARKET FROM VEGETABLE OILS, BY REGION, 2022–2025 (USD MILLION)
TABLE 70
OMEGA-3 MARKET FROM VEGETABLE OILS, BY REGION, 2026–2031 (USD MILLION)
TABLE 71
OMEGA-3 MARKET, BY APPLICATION, 2022–2025 (USD MILLION)
TABLE 72
OMEGA-3 MARKET, BY APPLICATION, 2026–2031 (USD MILLION)
TABLE 73
OMEGA-3 MARKET IN DIETARY SUPPLEMENTS, BY REGION, 2022–2025 (USD MILLION)
TABLE 74
OMEGA-3 MARKET IN DIETARY SUPPLEMENTS, BY REGION, 2026–2031 (USD MILLION)
TABLE 75
OMEGA-3 MARKET IN FUNCTIONAL FOODS & BEVERAGES, BY REGION, 2022–2025 (USD MILLION)
TABLE 76
OMEGA-3 MARKET IN FUNCTIONAL FOODS & BEVERAGES, BY REGION, 2026–2031 (USD MILLION)
TABLE 77
OMEGA-3 MARKET IN PHARMACEUTICALS, BY REGION, 2022–2025 (USD MILLION)
TABLE 78
OMEGA-3 MARKET IN PHARMACEUTICALS, BY REGION, 2026–2031 (USD MILLION)
TABLE 79
OMEGA-3 MARKET IN INFANT FORMULAS, BY REGION, 2022–2025 (USD MILLION)
TABLE 80
OMEGA-3 MARKET IN INFANT FORMULAS, BY REGION, 2026–2031 (USD MILLION)
TABLE 81
OMEGA-3 MARKET IN PET FOOD & FEED, BY REGION, 2022–2025 (USD MILLION)
TABLE 82
OMEGA-3 MARKET IN PET FOOD & FEED, BY REGION, 2026–2031 (USD MILLION)
TABLE 83
OMEGA-3 MARKET, BY FORM, 2022–2025 (USD MILLION)
TABLE 84
OMEGA-3 MARKET, BY FORM, 2026–2031 (USD MILLION)
TABLE 85
DRY OMEGA-3 MARKET, BY REGION, 2022–2025 (USD MILLION)
TABLE 86
DRY OMEGA-3 MARKET, BY REGION, 2026–2031 (USD MILLION)
TABLE 87
LIQUID OMEGA-3 MARKET, BY REGION, 2022–2025 (USD MILLION)
TABLE 88
LIQUID OMEGA-3 MARKET, BY REGION, 2026–2031 (USD MILLION)
TABLE 89
OMEGA-3 MARKET, BY REGION, 2022–2025 (USD MILLION)
TABLE 90
OMEGA-3 MARKET, BY REGION, 2026–2031 (USD MILLION)
TABLE 91
OMEGA-3 MARKET, BY REGION, 2022–2025 (KILOTONS)
TABLE 92
OMEGA-3 MARKET, BY REGION, 2026–2031 (KILOTONS)
TABLE 93
NORTH AMERICA: OMEGA-3 MARKET, BY COUNTRY, 2022–2025 (USD MILLION)
TABLE 94
NORTH AMERICA: OMEGA-3 MARKET, BY COUNTRY, 2026–2031 (USD MILLION)
TABLE 95
NORTH AMERICA: OMEGA-3 MARKET, BY TYPE, 2022–2025 (USD MILLION)
TABLE 96
NORTH AMERICA: OMEGA-3 MARKET, BY TYPE, 2026–2031 (USD MILLION)
TABLE 97
NORTH AMERICA: OMEGA-3 MARKET, BY APPLICATION, 2022–2025 (USD MILLION)
TABLE 98
NORTH AMERICA: OMEGA-3 MARKET, BY APPLICATION, 2026–2031 (USD MILLION)
TABLE 99
NORTH AMERICA: OMEGA-3 MARKET, BY SOURCE, 2022–2025 (USD MILLION)
TABLE 100
NORTH AMERICA: OMEGA-3 MARKET, BY SOURCE, 2026–2031 (USD MILLION)
TABLE 101
NORTH AMERICA: OMEGA-3 MARKET, BY SOURCE, 2022–2025 (KILOTONS)
TABLE 102
NORTH AMERICA: OMEGA-3 MARKET, BY SOURCE, 2026–2031 (KILOTONS)
TABLE 103
NORTH AMERICA: MARINE OMEGA-3 MARKET, BY SOURCE TYPE, 2022–2025 (USD MILLION)
TABLE 104
NORTH AMERICA: MARINE OMEGA-3 MARKET, BY SOURCE TYPE, 2026–2031 (USD MILLION)
TABLE 105
NORTH AMERICA: PLANT OMEGA-3 MARKET, BY SOURCE TYPE, 2022–2025 (USD MILLION)
TABLE 106
NORTH AMERICA: PLANT OMEGA-3 MARKET, BY SOURCE TYPE, 2026–2031 (USD MILLION)
TABLE 107
US: OMEGA-3 MARKET, BY TYPE, 2022–2025 (USD MILLION)
TABLE 108
US: OMEGA-3 MARKET, BY TYPE, 2026–2031 (USD MILLION)
TABLE 109
US: OMEGA-3 MARKET, BY SOURCE, 2022–2025 (USD MILLION)
TABLE 110
US: OMEGA-3 MARKET, BY SOURCE, 2026–2031 (USD MILLION)
TABLE 111
CANADA: OMEGA-3 MARKET, BY TYPE, 2022–2025 (USD MILLION)
TABLE 112
CANADA: OMEGA-3 MARKET, BY TYPE, 2026–2031 (USD MILLION)
TABLE 113
CANADA: OMEGA-3 MARKET, BY SOURCE, 2022–2025 (USD MILLION)
TABLE 114
CANADA: OMEGA-3 MARKET, BY SOURCE, 2026–2031 (USD MILLION)
TABLE 115
MEXICO: OMEGA-3 MARKET, BY TYPE, 2022–2025 (USD MILLION)
TABLE 116
MEXICO: OMEGA-3 MARKET, BY TYPE, 2026–2031 (USD MILLION)
TABLE 117
MEXICO: OMEGA-3 MARKET, BY SOURCE, 2022–2025 (USD MILLION)
TABLE 118
MEXICO: OMEGA-3 MARKET, BY SOURCE, 2026–2031 (USD MILLION)
TABLE 119
EUROPE: OMEGA-3 MARKET, BY COUNTRY, 2022–2025 (USD MILLION)
TABLE 120
EUROPE: OMEGA-3 MARKET, BY COUNTRY, 2026–2031 (USD MILLION)
TABLE 121
EUROPE: OMEGA-3 MARKET, BY TYPE, 2022–2025 (USD MILLION)
TABLE 122
EUROPE: OMEGA-3 MARKET, BY TYPE, 2026–2031 (USD MILLION)
TABLE 123
EUROPE: OMEGA-3 MARKET, BY APPLICATION, 2022–2025 (USD MILLION)
TABLE 124
EUROPE: OMEGA-3 MARKET, BY APPLICATION, 2026–2031 (USD MILLION)
TABLE 125
EUROPE: OMEGA-3 MARKET, BY SOURCE, 2022–2025 (USD MILLION)
TABLE 126
EUROPE: OMEGA-3 MARKET, BY SOURCE, 2026–2031 (USD MILLION)
TABLE 127
EUROPE: OMEGA-3 MARKET, BY SOURCE, 2022–2025 (KILOTONS)
TABLE 128
EUROPE: OMEGA-3 MARKET, BY SOURCE, 2026–2031 (KILOTONS)
TABLE 129
EUROPE: MARINE OMEGA-3 MARKET, BY SOURCE TYPE, 2022–2025 (USD MILLION)
TABLE 130
EUROPE: MARINE OMEGA-3 MARKET, BY SOURCE TYPE, 2026–2031 (USD MILLION)
TABLE 131
EUROPE: PLANT OMEGA-3 MARKET, BY SOURCE TYPE, 2022–2025 (USD MILLION)
TABLE 132
EUROPE: PLANT OMEGA-3 MARKET, BY SOURCE TYPE, 2026–2031 (USD MILLION)
TABLE 133
GERMANY: OMEGA-3 MARKET, BY TYPE, 2022–2025 (USD MILLION)
TABLE 134
GERMANY: OMEGA-3 MARKET, BY TYPE, 2026–2031 (USD MILLION)
TABLE 135
GERMANY: OMEGA-3 MARKET, BY SOURCE, 2022–2025 (USD MILLION)
TABLE 136
GERMANY: OMEGA-3 MARKET, BY SOURCE, 2026–2031 (USD MILLION)
TABLE 137
UK: OMEGA-3 MARKET, BY TYPE, 2022–2025 (USD MILLION)
TABLE 138
UK: OMEGA-3 MARKET, BY TYPE, 2026–2031 (USD MILLION)
TABLE 139
UK: OMEGA-3 MARKET, BY SOURCE, 2022–2025 (USD MILLION)
TABLE 140
UK: OMEGA-3 MARKET, BY SOURCE, 2026–2031 (USD MILLION)
TABLE 141
FRANCE: OMEGA-3 MARKET, BY TYPE, 2022–2025 (USD MILLION)
TABLE 142
FRANCE: OMEGA-3 MARKET, BY TYPE, 2026–2031 (USD MILLION)
TABLE 143
FRANCE: OMEGA-3 MARKET, BY SOURCE, 2022–2025 (USD MILLION)
TABLE 144
FRANCE: OMEGA-3 MARKET, BY SOURCE, 2026–2031 (USD MILLION)
TABLE 145
NORWAY: OMEGA-3 MARKET, BY TYPE, 2022–2025 (USD MILLION)
TABLE 146
NORWAY: OMEGA-3 MARKET, BY TYPE, 2026–2031 (USD MILLION)
TABLE 147
NORWAY: OMEGA-3 MARKET, BY SOURCE, 2022–2025 (USD MILLION)
TABLE 148
NORWAY: OMEGA-3 MARKET, BY SOURCE, 2026–2031 (USD MILLION)
TABLE 149
ITALY: OMEGA-3 MARKET, BY TYPE, 2022–2025 (USD MILLION)
TABLE 150
ITALY: OMEGA-3 MARKET, BY TYPE, 2026–2031 (USD MILLION)
TABLE 151
ITALY: OMEGA-3 MARKET, BY SOURCE, 2022–2025 (USD MILLION)
TABLE 152
ITALY: OMEGA-3 MARKET, BY SOURCE, 2026–2031 (USD MILLION)
TABLE 153
SPAIN: OMEGA-3 MARKET, BY TYPE, 2022–2025 (USD MILLION)
TABLE 154
SPAIN: OMEGA-3 MARKET, BY TYPE, 2026–2031 (USD MILLION)
TABLE 155
SPAIN: OMEGA-3 MARKET, BY SOURCE, 2022–2025 (USD MILLION)
TABLE 156
SPAIN: OMEGA-3 MARKET, BY SOURCE, 2026–2031 (USD MILLION)
TABLE 157
NETHERLANDS: OMEGA-3 MARKET, BY TYPE, 2022–2025 (USD MILLION)
TABLE 158
NETHERLANDS: OMEGA-3 MARKET, BY TYPE, 2026–2031 (USD MILLION)
TABLE 159
NETHERLANDS: OMEGA-3 MARKET, BY SOURCE, 2022–2025 (USD MILLION)
TABLE 160
NETHERLANDS: OMEGA-3 MARKET, BY SOURCE, 2026–2031 (USD MILLION)
TABLE 161
REST OF EUROPE: OMEGA-3 MARKET, BY TYPE, 2022–2025 (USD MILLION)
TABLE 162
REST OF EUROPE: OMEGA-3 MARKET, BY TYPE, 2026–2031 (USD MILLION)
TABLE 163
REST OF EUROPE: OMEGA-3 MARKET, BY SOURCE, 2022–2025 (USD MILLION)
TABLE 164
REST OF EUROPE: OMEGA-3 MARKET, BY SOURCE, 2026–2031 (USD MILLION)
TABLE 165
ASIA PACIFIC: OMEGA-3 MARKET, BY COUNTRY, 2022–2025 (USD MILLION)
TABLE 166
ASIA PACIFIC: OMEGA-3 MARKET, BY COUNTRY, 2026–2031 (USD MILLION)
TABLE 167
ASIA PACIFIC: OMEGA-3 MARKET, BY TYPE, 2022–2025 (USD MILLION)
TABLE 168
ASIA PACIFIC: OMEGA-3 MARKET, BY TYPE, 2026–2031 (USD MILLION)
TABLE 169
ASIA PACIFIC: OMEGA-3 MARKET, BY APPLICATION, 2022–2025 (USD MILLION)
TABLE 170
ASIA PACIFIC: OMEGA-3 MARKET, BY APPLICATION, 2026–2031 (USD MILLION)
TABLE 171
ASIA PACIFIC: OMEGA-3 MARKET, BY SOURCE, 2022–2025 (USD MILLION)
TABLE 172
ASIA PACIFIC: OMEGA-3 MARKET, BY SOURCE, 2026–2031 (USD MILLION)
TABLE 173
ASIA PACIFIC: OMEGA-3 MARKET, BY SOURCE, 2022–2025 (KILOTONS)
TABLE 174
ASIA PACIFIC: OMEGA-3 MARKET, BY SOURCE, 2026–2031 (KILOTONS)
TABLE 175
ASIA PACIFIC: MARINE OMEGA-3 MARKET, BY SOURCE TYPE, 2022–2025 (USD MILLION)
TABLE 176
ASIA PACIFIC: MARINE OMEGA-3 MARKET, BY SOURCE TYPE, 2026–2031 (USD MILLION)
TABLE 177
ASIA PACIFIC: PLANT OMEGA-3 MARKET, BY SOURCE TYPE, 2022–2025 (USD MILLION)
TABLE 178
ASIA PACIFIC: PLANT OMEGA-3 MARKET, BY SOURCE TYPE, 2026–2031 (USD MILLION)
TABLE 179
CHINA: OMEGA-3 MARKET, BY TYPE, 2022–2025 (USD MILLION)
TABLE 180
CHINA: OMEGA-3 MARKET, BY TYPE, 2026–2031 (USD MILLION)
TABLE 181
CHINA: OMEGA-3 MARKET, BY SOURCE, 2022–2025 (USD MILLION)
TABLE 182
CHINA: OMEGA-3 MARKET, BY SOURCE, 2026–2031 (USD MILLION)
TABLE 183
INDIA: OMEGA-3 MARKET, BY TYPE, 2022–2025 (USD MILLION)
TABLE 184
INDIA: OMEGA-3 MARKET, BY TYPE, 2026–2031 (USD MILLION)
TABLE 185
INDIA: OMEGA-3 MARKET, BY SOURCE, 2022–2025 (USD MILLION)
TABLE 186
INDIA: OMEGA-3 MARKET, BY SOURCE, 2026–2031 (USD MILLION)
TABLE 187
JAPAN: OMEGA-3 MARKET, BY TYPE, 2022–2025 (USD MILLION)
TABLE 188
JAPAN: OMEGA-3 MARKET, BY TYPE, 2026–2031 (USD MILLION)
TABLE 189
JAPAN: OMEGA-3 MARKET, BY SOURCE, 2022–2025 (USD MILLION)
TABLE 190
JAPAN: OMEGA-3 MARKET, BY SOURCE, 2026–2031 (USD MILLION)
TABLE 191
AUSTRALIA & NEW ZEALAND: OMEGA-3 MARKET, BY TYPE, 2022–2025 (USD MILLION)
TABLE 192
AUSTRALIA & NEW ZEALAND: OMEGA-3 MARKET, BY TYPE, 2026–2031 (USD MILLION)
TABLE 193
AUSTRALIA & NEW ZEALAND: OMEGA-3 MARKET, BY SOURCE, 2022–2025 (USD MILLION)
TABLE 194
AUSTRALIA & NEW ZEALAND: OMEGA-3 MARKET, BY SOURCE, 2026–2031 (USD MILLION)
TABLE 195
REST OF ASIA PACIFIC: OMEGA-3 MARKET, BY TYPE, 2022–2025 (USD MILLION)
TABLE 196
REST OF ASIA PACIFIC: OMEGA-3 MARKET, BY TYPE, 2026–2031 (USD MILLION)
TABLE 197
REST OF ASIA PACIFIC: OMEGA-3 MARKET, BY SOURCE, 2022–2025 (USD MILLION)
TABLE 198
REST OF ASIA PACIFIC: OMEGA-3 MARKET, BY SOURCE, 2026–2031 (USD MILLION)
TABLE 199
SOUTH AMERICA: OMEGA-3 MARKET, BY COUNTRY, 2022–2025 (USD MILLION)
TABLE 200
SOUTH AMERICA: OMEGA-3 MARKET, BY COUNTRY, 2026–2031 (USD MILLION)
TABLE 201
SOUTH AMERICA: OMEGA-3 MARKET, BY TYPE, 2022–2025 (USD MILLION)
TABLE 202
SOUTH AMERICA: OMEGA-3 MARKET, BY TYPE, 2026–2031 (USD MILLION)
TABLE 203
SOUTH AMERICA: OMEGA-3 MARKET, BY APPLICATION, 2022–2025 (USD MILLION)
TABLE 204
SOUTH AMERICA: OMEGA-3 MARKET, BY APPLICATION, 2026–2031 (USD MILLION)
TABLE 205
SOUTH AMERICA: OMEGA-3 MARKET, BY SOURCE, 2022–2025 (USD MILLION)
TABLE 206
SOUTH AMERICA: OMEGA-3 MARKET, BY SOURCE, 2026–2031 (USD MILLION)
TABLE 207
SOUTH AMERICA: OMEGA-3 MARKET, BY SOURCE, 2022–2025 (KILOTONS)
TABLE 208
SOUTH AMERICA: OMEGA-3 MARKET, BY SOURCE, 2026–2031 (KILOTONS)
TABLE 209
SOUTH AMERICA: MARINE OMEGA-3 MARKET, BY SOURCE TYPE, 2022–2025 (USD MILLION)
TABLE 210
SOUTH AMERICA: MARINE OMEGA-3 MARKET, BY SOURCE TYPE, 2026–2031 (USD MILLION)
TABLE 211
SOUTH AMERICA: PLANT OMEGA-3 MARKET, BY SOURCE TYPE, 2022–2025 (USD MILLION)
TABLE 212
SOUTH AMERICA: PLANT OMEGA-3 MARKET, BY SOURCE TYPE, 2026–2031 (USD MILLION)
TABLE 213
BRAZIL: OMEGA-3 MARKET, BY TYPE, 2022–2025 (USD MILLION)
TABLE 214
BRAZIL: OMEGA-3 MARKET, BY TYPE, 2026–2031 (USD MILLION)
TABLE 215
BRAZIL: OMEGA-3 MARKET, BY SOURCE, 2022–2025 (USD MILLION)
TABLE 216
BRAZIL: OMEGA-3 MARKET, BY SOURCE, 2026–2031 (USD MILLION)
TABLE 217
ARGENTINA: OMEGA-3 MARKET, BY TYPE, 2022–2025 (USD MILLION)
TABLE 218
ARGENTINA: OMEGA-3 MARKET, BY TYPE, 2026–2031 (USD MILLION)
TABLE 219
ARGENTINA: OMEGA-3 MARKET, BY SOURCE, 2022–2025 (USD MILLION)
TABLE 220
ARGENTINA: OMEGA-3 MARKET, BY SOURCE, 2026–2031 (USD MILLION)
TABLE 221
REST OF SOUTH AMERICA: OMEGA-3 MARKET, BY TYPE, 2022–2025 (USD MILLION)
TABLE 222
REST OF SOUTH AMERICA: OMEGA-3 MARKET, BY TYPE, 2026–2031 (USD MILLION)
TABLE 223
REST OF SOUTH AMERICA: OMEGA-3 MARKET, BY SOURCE, 2022–2025 (USD MILLION)
TABLE 224
REST OF SOUTH AMERICA: OMEGA-3 MARKET, BY SOURCE, 2026–2031 (USD MILLION)
TABLE 225
ROW: OMEGA-3 MARKET, BY REGION, 2022–2025 (USD MILLION)
TABLE 226
ROW: OMEGA-3 MARKET, BY REGION, 2026–2031 (USD MILLION)
TABLE 227
ROW: OMEGA-3 MARKET, BY TYPE, 2022–2025 (USD MILLION)
TABLE 228
ROW: OMEGA-3 MARKET, BY TYPE, 2026–2031 (USD MILLION)
TABLE 229
ROW: OMEGA-3 MARKET, BY APPLICATION, 2022–2025 (USD MILLION)
TABLE 230
ROW: OMEGA-3 MARKET, BY APPLICATION, 2026–2031 (USD MILLION)
TABLE 231
ROW: OMEGA-3 MARKET, BY SOURCE, 2022–2025 (USD MILLION)
TABLE 232
ROW: OMEGA-3 MARKET, BY SOURCE, 2026–2031 (USD MILLION)
TABLE 233
ROW: OMEGA-3 MARKET, BY SOURCE, 2022–2025 (KILOTONS)
TABLE 234
ROW: OMEGA-3 MARKET, BY SOURCE, 2026–2031 (KILOTONS)
TABLE 235
ROW: MARINE OMEGA-3 MARKET, BY SOURCE TYPE, 2022–2025 (USD MILLION)
TABLE 236
ROW: MARINE OMEGA-3 MARKET, BY SOURCE TYPE, 2026–2031 (USD MILLION)
TABLE 237
ROW: PLANT OMEGA-3 MARKET, BY SOURCE TYPE, 2022–2025 (USD MILLION)
TABLE 238
ROW: PLANT OMEGA-3 MARKET, BY SOURCE TYPE, 2026–2031 (USD MILLION)
TABLE 239
AFRICA: OMEGA-3 MARKET, BY TYPE, 2022–2025 (USD MILLION)
TABLE 240
AFRICA: OMEGA-3 MARKET, BY TYPE, 2026–2031 (USD MILLION)
TABLE 241
AFRICA: OMEGA-3 MARKET, BY SOURCE, 2022–2025 (USD MILLION)
TABLE 242
AFRICA: OMEGA-3 MARKET, BY SOURCE, 2026–2031 (USD MILLION)
TABLE 243
MIDDLE EAST: OMEGA-3 MARKET, BY TYPE, 2022–2025 (USD MILLION)
TABLE 244
MIDDLE EAST: OMEGA-3 MARKET, BY TYPE, 2026–2031 (USD MILLION)
TABLE 245
MIDDLE EAST: OMEGA-3 MARKET, BY SOURCE, 2022–2025 (USD MILLION)
TABLE 246
MIDDLE EAST: OMEGA-3 MARKET, BY SOURCE, 2026–2031 (USD MILLION)
TABLE 247
OVERVIEW OF STRATEGIES ADOPTED BY KEY OMEGA-3 MARKET PLAYERS
TABLE 248
OMEGA-3 MARKET: MARKET SHARE ANALYSIS, 2025
TABLE 249
OMEGA-3 MARKET: REGIONAL FOOTPRINT, 2024
TABLE 250
OMEGA-3 MARKET: SOURCE FOOTPRINT, 2024
TABLE 251
OMEGA-3 MARKET: TYPE FOOTPRINT, 2024
TABLE 252
OMEGA-3 MARKET: APPLICATION FOOTPRINT, 2024
TABLE 253
OMEGA-3 MARKET: DETAILED LIST OF KEY STARTUPS/SMES
TABLE 254
OMEGA-3 MARKET: COMPETITIVE BENCHMARKING OF STARTUPS/SMES
TABLE 255
OMEGA-3 MARKET: PRODUCT LAUNCHES, JUNE 2022–JULY 2026
TABLE 256
OMEGA-3 MARKET: DEALS, DECEMBER 2022–JULY 2026
TABLE 257
OMEGA-3 MARKET: EXPANSIONS, FEBRUARY 2020–JULY 2026
TABLE 258
DSM-FIRMENICH: COMPANY OVERVIEW
TABLE 259
DSM-FIRMENICH: PRODUCTS/SOLUTIONS/SERVICES OFFERED
TABLE 260
DSM-FIRMENICH: PRODUCT LAUNCHES AND ENHANCEMENTS
TABLE 261
CARGILL, INCORPORATED: COMPANY OVERVIEW
TABLE 262
CARGILL, INCORPORATED: PRODUCTS/SOLUTIONS/SERVICES OFFERED
TABLE 263
CARGILL, INCORPORATED: DEALS
TABLE 264
BASF SE: COMPANY OVERVIEW
TABLE 265
BASF SE: PRODUCTS/SOLUTIONS/SERVICES OFFERED
TABLE 266
BASF SE: DEALS
TABLE 267
ADM: COMPANY OVERVIEW
TABLE 268
ADM: PRODUCTS/SOLUTIONS/SERVICES OFFERED
TABLE 269
KERRY GROUP PLC: COMPANY OVERVIEW
TABLE 270
KERRY GROUP PLC: PRODUCTS/SOLUTIONS/SERVICES OFFERED
TABLE 271
KERRY GROUP PLC: DEALS
TABLE 272
CORBION: COMPANY OVERVIEW
TABLE 273
CORBION: PRODUCTS/SOLUTIONS/SERVICES OFFERED
TABLE 274
CORBION: PRODUCT LAUNCHES AND ENHANCEMENTS
TABLE 275
CORBION: OTHER DEVELOPMENTS
TABLE 276
KD PHARMA GROUP SA: COMPANY OVERVIEW
TABLE 277
KD PHARMA GROUP SA: PRODUCTS/SOLUTIONS/SERVICES OFFERED
TABLE 278
KD PHARMA GROUP SA: DEALS
TABLE 279
KD PHARMA GROUP SA: EXPANSIONS
TABLE 280
AKER BIOMARINE: COMPANY OVERVIEW
TABLE 281
AKER BIOMARINE: PRODUCTS/SOLUTIONS/SERVICES OFFERED
TABLE 282
AKER BIOMARINE: PRODUCT LAUNCHES AND ENHANCEMENTS
TABLE 283
AKER BIOMARINE: EXPANSIONS
TABLE 284
AKER BIOMARINE: DEALS
TABLE 285
AKER BIOMARINE: OTHER DEVELOPMENTS
TABLE 286
CRODA INTERNATIONAL PLC: COMPANY OVERVIEW
TABLE 287
CRODA INTERNATIONAL PLC: PRODUCTS/SOLUTIONS/SERVICES OFFERED
TABLE 288
EVONIK INDUSTRIES AG: COMPANY OVERVIEW
TABLE 289
EVONIK INDUSTRIES AG: PRODUCTS/SOLUTIONS/SERVICES OFFERED
TABLE 290
EVONIK INDUSTRIES AG: DEALS
TABLE 291
PELAGIA: COMPANY OVERVIEW
TABLE 292
PELAGIA: PRODUCTS/SOLUTIONS/SERVICES OFFERED
TABLE 293
PELAGIA: PRODUCT LAUNCHES AND ENHANCEMENTS
TABLE 294
PELAGIA AS: OTHER DEVELOPMENTS
TABLE 295
GC RIEBER: COMPANY OVERVIEW
TABLE 296
GC RIEBER: PRODUCTS/SOLUTIONS/SERVICES OFFERED
TABLE 297
GC RIEBER: PRODUCT LAUNCHES AND ENHANCEMENTS
TABLE 298
GC RIEBER: EXPANSIONS
TABLE 299
COOKE AQUACULTURE INC.: COMPANY OVERVIEW
TABLE 300
COOKE AQUACULTURE INC.: PRODUCTS/SOLUTIONS/SERVICES OFFERED
TABLE 301
COOKE AQUACULTURE INC.: DEALS
TABLE 302
ALGISYS BIOSCIENCES, INC.: COMPANY OVERVIEW
TABLE 303
ALGISYS BIOSCIENCES, INC.: PRODUCTS/SOLUTIONS/SERVICES OFFERED
TABLE 304
ALGISYS BIOSCIENCES, INC.: OTHER DEVELOPMENTS
TABLE 305
POLARIS: COMPANY OVERVIEW
TABLE 306
POLARIS: PRODUCTS/SOLUTIONS/SERVICES OFFERED
TABLE 307
POLARIS: PRODUCT LAUNCHES AND ENHANCEMENTS
TABLE 308
POLARIS: OTHER DEVELOPMENTS
TABLE 309
BTSA: COMPANY OVERVIEW
TABLE 310
BTSA: PRODUCTS/SOLUTIONS/SERVICES OFFERED
TABLE 311
NOVOSANA EUROPE B.V.: COMPANY OVERVIEW
TABLE 312
NOVOSANA EUROPE B.V.: PRODUCTS/SOLUTIONS/SERVICES OFFERED
TABLE 313
GOLDEN OMEGA: COMPANY OVERVIEW
TABLE 314
GOLDEN OMEGA: PRODUCTS/SOLUTIONS/SERVICES OFFERED
TABLE 315
GOLDEN OMEGA: DEALS
TABLE 316
KINOMEGA BIOPHARM INC.: COMPANY OVERVIEW
TABLE 317
KINOMEGA BIOPHARM INC.: PRODUCTS/SOLUTIONS/SERVICES OFFERED
TABLE 318
RIMFROST AS: COMPANY OVERVIEW
TABLE 319
RIMFROST AS: PRODUCTS/SOLUTIONS/SERVICES OFFERED
TABLE 320
RIMFROST AS: DEALS
TABLE 321
MARKETS ADJACENT TO OMEGA-3 MARKET
TABLE 322
FUNCTIONAL FOOD INGREDIENTS MARKET, BY SOURCE, 2019–2023 (USD MILLION)
TABLE 323
FUNCTIONAL FOOD INGREDIENTS MARKET, BY SOURCE, 2024–2029 (USD MILLION)
TABLE 324
MARINE COLLAGEN MARKET, BY FORM, 2022–2025 (USD MILLION)
TABLE 325
MARINE COLLAGEN MARKET, BY FORM, 2026–2031 (USD MILLION)
LIST OF FIGURES
FIGURE 1
OMEGA-3 MARKETS COVERED
FIGURE 2
STUDY YEARS CONSIDERED
FIGURE 3
MARKET SCENARIO
FIGURE 4
OMEGA-3 MARKET, 2022–2031
FIGURE 5
MAJOR STRATEGIES ADOPTED BY KEY PLAYERS IN OMEGA-3 MARKET, JULY 2021–MAY 2026
FIGURE 6
DISRUPTIONS INFLUENCING GROWTH OF OMEGA-3 MARKET
FIGURE 7
OMEGA-3 MARKET: HIGH-GROWTH SEGMENTS, 2026–2031
FIGURE 8
ASIA PACIFIC TO REGISTER HIGHEST CAGR DURING FORECAST PERIOD
FIGURE 9
INCREASING DEMAND FOR OMEGA-3 ACROSS FUNCTIONAL FOODS AND DIETARY SUPPLEMENTS TO SUPPORT MARKET GROWTH
FIGURE 10
TYPE SEGMENT DOCOSAHEXAENOIC ACID (DHA) AND NORTH AMERICA REGION TO ACCOUNT FOR LARGEST MARKET SHARES IN 2026
FIGURE 11
OMEGA-3 DOCOSAHEXAENOIC ACID (DHA) TYPE SEGMENT TO LEAD MARKET IN 2026
FIGURE 12
MARINE SEGMENT TO ACCOUNT FOR LARGEST MARKET SHARE IN 2026
FIGURE 13
BY FORM SEGMENT DRY FORM SEGMENT TO DOMINATE MARKET IN 2026
FIGURE 14
DIETARY SUPPLEMENTS APPLICATION SEGMENT TO DOMINATE MARKET IN 2026
FIGURE 15
US TO ACCOUNT FOR LARGEST MARKET SHARE IN 2026
FIGURE 16
OMEGA-3 MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
FIGURE 17
RECOMMENDED EPA LEVELS IN DOG FOOD (MG)
FIGURE 18
MICROALGAE PROCESSING FOR OMEGA-3
FIGURE 19
OMEGA-3 MARKET: PORTER’S FIVE FORCES ANALYSIS
FIGURE 20
PREVENTIVE HEALTHCARE EXPENDITURE AS PERCENTAGE OF GDP, BY COUNTRY, 2023
FIGURE 21
GLOBAL POPULATION AGED 65 AND ABOVE (% OF TOTAL POPULATION), 2014–2025
FIGURE 22
OMEGA-3 MARKET: VALUE CHAIN ANALYSIS
FIGURE 23
OMEGA-3 MARKET ECOSYSTEM MAP
FIGURE 24
AVERAGE SELLING PRICE OF OMEGA-3 FINISHED PRODUCTS, BY PRODUCT TYPE, 2025 (USD)
FIGURE 25
AVERAGE SELLING PRICE (ASP) TREND, BY REGION, 2022–2025 (USD/TON)
FIGURE 26
IMPORT OF HS CODE 1504, BY KEY COUNTRY, 2022–2025 (USD)
FIGURE 27
EXPORT OF HS CODE 1504, BY KEY COUNTRY, 2022–2025 (USD)
FIGURE 28
TRENDS/DISRUPTIONS INFLUENCING CUSTOMERS’ BUSINESSES
FIGURE 29
INVESTMENT AND FUNDING SCENARIO
FIGURE 30
NUMBER OF PATENTS GRANTED BETWEEN 2016 AND 2026
FIGURE 31
FUTURE APPLICATIONS
FIGURE 32
OMEGA-3 MARKET DECISION-MAKING FACTORS
FIGURE 33
INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR KEY PRODUCT TYPES
FIGURE 34
KEY BUYING CRITERIA FOR TOP PRODUCT TYPES
FIGURE 35
ADOPTION BARRIERS AND INTERNAL CHALLENGES
FIGURE 36
OMEGA-3 MARKET, BY TYPE, 2026 VS. 2031 (USD MILLION)
FIGURE 37
OMEGA-3 MARKET, BY SOURCE, 2026 VS. 2031 (USD MILLION)
FIGURE 38
OMEGA-3 MARKET, BY APPLICATION, 2026 VS. 2031 (USD MILLION)
FIGURE 39
OMEGA-3 MARKET, BY FORM, 2026 VS. 2031 (USD MILLION)
FIGURE 40
INDIA TO RECORD HIGHEST GROWTH RATE IN THE OMEGA-3 MARKET
FIGURE 41
NORTH AMERICA: REGIONAL SNAPSHOT
FIGURE 42
ASIA PACIFIC: REGIONAL SNAPSHOT
FIGURE 43
REVENUE ANALYSIS OF KEY PLAYERS, 2023–2025 (USD BILLION)
FIGURE 44
OMEGA-3 MARKET SHARE ANALYSIS, 2025
FIGURE 45
COMPANY VALUATION FOR MAJOR PLAYERS IN OMEGA-3 MARKET
FIGURE 46
EV/EBITDA OF MAJOR PLAYERS
FIGURE 47
OMEGA-3 MARKET: BRAND/PRODUCT COMPARISON
FIGURE 48
OMEGA-3 MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2025
FIGURE 49
OMEGA-3 MARKET: COMPANY FOOTPRINT, 2024
FIGURE 50
OMEGA-3 MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2024
FIGURE 51
DSM-FIRMENICH: COMPANY SNAPSHOT
FIGURE 52
CARGILL, INCORPORATED: COMPANY SNAPSHOT
FIGURE 53
BASF SE: COMPANY SNAPSHOT
FIGURE 54
ADM: COMPANY SNAPSHOT
FIGURE 55
KERRY GROUP PLC: COMPANY SNAPSHOT
FIGURE 56
CORBION: COMPANY SNAPSHOT
FIGURE 57
KD PHARMA GROUP SA: COMPANY SNAPSHOT
FIGURE 58
AKER BIOMARINE: COMPANY SNAPSHOT
FIGURE 59
CRODA INTERNATIONAL PLC: COMPANY SNAPSHOT
FIGURE 60
EVONIK INDUSTRIES AG: COMPANY SNAPSHOT
FIGURE 61
PELAGIA: COMPANY SNAPSHOT
FIGURE 62
GC RIEBER: COMPANY SNAPSHOT
FIGURE 63
OMEGA-3 MARKET: RESEARCH DESIGN
FIGURE 64
BREAKDOWN OF PRIMARY INTERVIEWS, BY COMPANY TYPE, DESIGNATION, AND REGION
FIGURE 65
MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH
FIGURE 66
SUPPLY-SIDE ANALYSIS: SOURCES OF INFORMATION AT EVERY STEP
FIGURE 67
OMEGA-3 MARKET SIZE ESTIMATION: BOTTOM-UP APPROACH
FIGURE 68
DATA TRIANGULATION
Methodology
This study involved two major approaches in estimating the current size of the omega-3 market. Exhaustive secondary research was done to collect information on the type, source, application, form, and manufacturing technology (qualitative) segments of the market. The next step involved validating these findings, assumptions, and sizing with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were employed to estimate the complete market size. Thereafter, data triangulation was used to estimate the market size of segments and subsegments.
Secondary Research
This research study involved the use of extensive secondary sources—directories and databases such as Bloomberg Businessweek and Factiva—to identify and collect information useful for a technical, market-oriented, and commercial market study. In the secondary research process, sources such as annual reports, press releases & investor presentations of companies, white papers, food journals, certified publications, articles from recognized authors, directories, and databases were referred to to identify and collect information. Secondary research was mainly used to obtain key information about the industry’s supply chain, the pool of key players, and market classification and segmentation as per the industry trends to the bottom-most level, regional markets, and key developments from market- and technology-oriented perspectives.
Primary Research
Extensive primary research was conducted after obtaining information regarding the omega-3 market scenario through secondary research. Several primary interviews were conducted with market experts from the demand and supply sides across major countries of North America, Europe, Asia Pacific, South America, and the Rest of the World. Primary data was collected through questionnaires, emails, and telephonic interviews. The primary sources from the supply side included various industry experts, such as chief experience officers (CXOs), vice presidents (VPs), directors from business development, marketing, research, and development teams, and related key executives from distributors and key opinion leaders. Primary interviews were conducted to gather insights such as market statistics, data on revenue collected from the products and services, market breakdowns, market size estimations, market forecasting, and data triangulation. Primary research also helped understand the various trends related to type, source, application, form, and region. Stakeholders from the demand side, such as functional food & beverage manufacturers, dietary supplement manufacturers, pharmaceutical product manufacturers, infant formula manufacturers, and pet-food & feed product manufacturers, were interviewed to understand the buyers’ perspective on the suppliers, products, and the outlook of their business, which will affect the overall market.
Note: The three tiers of the companies are defined based on their total revenues in 2023 or 2024, as per the availability of financial data: Tier 1: Revenue >USD 1 billion; Tier 2: USD 100 million ≤ revenue ≤ USD 1 billion; Tier 3: Revenue <USD 100 million. RoW includes Africa and the Middle East
|
COMPANY NAME |
DESIGNATION |
|
Cargill, Incorporated (US) |
Product Development Manager |
|
Kerry Group plc (Ireland) |
Sales Head |
|
Corbion (Netherlands) |
Marketing Head |
|
Golden Omega (Chile) |
Sales Head |
|
DSM-Firmenich (Netherlands) |
Senior Research Executive |
|
Algalr Nutrapharms Private Limited (India) |
Business Development Manager |
To know about the assumptions considered for the study, download the pdf brochure
Market Size Estimation
The top-down and bottom-up approaches were used to estimate and validate the total size of the omega-3 market. These approaches were also used extensively to determine the size of various subsegments in the market. The research methodology used to estimate the market size includes the following details:
- The key players in the industry and the overall markets were identified through extensive secondary research.
- All shares, splits, and breakdowns were determined using secondary sources and verified through primary sources.
- All possible parameters that affect the market covered in this research study were accounted for, viewed in extensive detail, verified through primary research, and analyzed to obtain final quantitative and qualitative data.
- The research included the study of reports, reviews, and newsletters of top market players, along with extensive interviews for opinions from leaders, such as CEOs, directors, and marketing executives.
Data Triangulation
After determining the overall market size from the estimation process explained above, the total market was split into several segments and subsegments. The data triangulation procedure was employed, wherever applicable, to estimate the overall omega-3 market and arrive at the exact statistics for all segments and subsegments. The data was triangulated by studying various factors and trends from the demand and supply sides. The market size was also validated using both the top-down and bottom-up approaches.
Market Definition
According to the US Department of Health & Human Services, "Omega-3 fatty acids (omega-3s) have a carbon-carbon double bond located three carbons from the methyl end of the chain. Omega-3s, sometimes referred to as 'n-3s,' are present in certain foods, such as flaxseed and fish, as well as dietary supplements, such as fish oil. Several different omega-3s exist, but the majority of scientific research focuses on three: alpha-linolenic acid (ALA), eicosapentaenoic acid (EPA), and docosahexaenoic acid (DHA). ALA contains 18 carbon atoms, whereas EPA and DHA are considered "long-chain" (LC) omega-3s because EPA contains 20 carbons, and DHA contains 22. ALA is found mainly in plant oils, such as flaxseed, soybean, and canola. DHA and EPA are found in fish and other seafood.
Key Stakeholders
- Raw material suppliers of omega-3
- Omega-3 ingredient manufacturers, suppliers, and dealers
- API, pharmaceutical products, and fortified food manufacturers
- Fisheries and farms
- Intermediate stakeholders, including distributors, retailers, associations, regulatory bodies, and others
- Manufacturers and traders of food & beverage products, dietary supplements, infant formulas, pharmaceuticals, and pet food & feed
- Government organizations, institutes, and research organizations
- Associations and industry bodies:
-
- Food and Agriculture Organization (FAO)
- US Department of Agriculture (USDA)
- US Food and Drug Administration (FDA)
- Food Processing Suppliers Association (FPSA)
- Global Organization for EPA and DHA Omega-3s (GOED)
- Food Safety and Standards Authority of India (FSSAI)
- International Fish Oil Standards Program (IFOS)
- European Food Safety Authority (EFSA)
Report Objectives
- To determine and project the size of the omega-3 market based on type, source, application, form, manufacturing technology (qualitative), and region, over five years, ranging from 2025 to 2030
- To identify the attractive opportunities in the market by determining the largest and fastest-growing segments across regions
- To provide detailed information about the key factors influencing market growth (drivers, restraints, opportunities, and challenges)
- To analyze the opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
- To analyze the micromarkets with respect to individual growth trends, prospects, and their contribution to the total market
- To identify and profile the key players in the market
- To understand the competitive landscape and identify the major growth strategies adopted by players across the key regions
Customization Options:
ith the given market data, MarketsandMarkets offers customizations according to company-specific scientific needs. The following customization options are available for the report:
PRODUCT ANALYSIS
- Product matrix, which gives a detailed comparison of the product portfolio of each company.
GEOGRAPHIC ANALYSIS
- With the given market data, MarketsandMarkets offers customizations according to company-specific scientific needs.
- Further breakdown of the Rest of Europe omega-3 market into key countries
- Further breakdown of the Rest of Asia Pacific omega-3 market into key countries
- Further breakdown of the Rest of South America omega-3 market into key countries
COMPANY INFORMATION
- Detailed analyses and profiling of additional market players (up to five)
Key Questions Addressed by the Report
What is the current size of the Omega-3 Market?
The omega-3 market is estimated to be USD 4.88 billion in 2026 and is projected to reach USD 8.73 billion by 2031, at a CAGR of 12.3%. Market expansion is being driven by increasing consumer awareness of cardiovascular, cognitive, eye, and joint health benefits, along with rising demand for dietary supplements and functional foods.
What is driving the growth of the Omega-3 Market?
The Omega-3 Market is growing due to rising health consciousness, increasing prevalence of lifestyle-related diseases, growing demand for preventive nutrition, expanding use of omega-3 ingredients in pharmaceuticals and infant nutrition, and continuous innovation in algae-based and marine-derived omega-3 products.
What are the major trends shaping the Omega-3 Market?
Key market trends include increasing adoption of plant-based omega-3 ingredients, rising demand for clean-label nutritional supplements, growing use of algae-derived DHA, expansion of personalized nutrition, and technological advancements that improve ingredient stability and bioavailability.
What opportunities exist in the Omega-3 Market?
Significant opportunities are emerging in functional beverages, sports nutrition, infant formula, healthy aging products, pharmaceutical applications, pet nutrition, and sustainable algae-based omega-3 production as consumers increasingly seek science-backed wellness products.
Which region leads the Omega-3 Market?
North America holds the largest share of the global Omega-3 Market due to high supplement consumption, strong consumer awareness, advanced healthcare infrastructure, and growing demand for functional nutrition products.
Fact checked
Personalize This Research
- Triangulate with your Own Data
- Get Data as per your Format and Definition
- Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
- Any level of Personalization
Let Us Help You
- What are the Known and Unknown Adjacencies Impacting the Omega-3 Market
- What will your New Revenue Sources be?
- Who will be your Top Customer; what will make them switch?
- Defend your Market Share or Win Competitors
- Get a Scorecard for Target Partners
Custom Market Research Services
We Will Customise The Research For You, In Case The Report Listed Above Does Not Meet With Your Requirements
Get 10% Free CustomisationTESTIMONIALS
Business Innovation Director
US Based Leading Agribusiness,
Food and Ingredients ManufacturerI highly appreciate the team's efficiency for a well conducted study that helped us clarify some blind spots in food and agricultural niche markets. Although compiling information for B2B markets is very difficult, the MnM team pulled out the task successfully. The quality of research, level of insights, and responsiveness of team were commendable.
- US Omega-3 Market
- Canada Omega-3 Market
- Mexico Omega-3 Market
- Germany Omega-3 Market
- UK Omega-3 Market
- France Omega-3 Market
- Norway Omega-3 Market
- Italy Omega-3 Market
- Spain Omega-3 Market
- Netherlands Omega-3 Market
- China Omega-3 Market
- India Omega-3 Market
- Japan Omega-3 Market
- Brazil Omega-3 Market
- Argentina Omega-3 Market
Growth opportunities and latent adjacency in Omega-3 Market
Nelson
Nov, 2020
Our company requires an Omega-3 market forecast till 2026, along with other global market metrics..
User
Apr, 2022
I would like to understand more about the potential opportunities for entering the omega-3 market. Is it included in the report?.
User
Apr, 2022
I am working on omega-3 market and would require data related to its application in infant foods and pet food supplements..